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ABSTRACT
Genome instability is a characteristic of cancer and
aging, and is a hallmark of the premature aging
disorder Werner syndrome (WS). Evidence suggests
that the Werner syndrome protein (WRN) contributes
to the maintenance of genome integrity through its
involvement in DNA repair. In particular, biochemical
evidence indicates a role for WRN in base excision
repair (BER). We have previously reported that WRN
helicase activity stimulates DNA polymerase beta
(pol b) strand displacement synthesis in vitro.
In this report we demonstrate that WRN exonuclease
activitycanactcooperativelywithpolb,apolymerase
lacking 30–50 proofreading activity. Furthermore,
using small interference RNA technology, we
demonstrate that WRN knockdown cells are hyper-
sensitive to the alkylating agent methyl methanesul-
fonate, which creates DNA damage that is primarily
repaired by the BER pathway. In addition, repair
assays using whole cell extracts from WRN knock-
down cells indicate a defect in long patch (LP) BER.
These findings demonstrate that WRN plays a direct
role in the repair of methylation-induced DNA
damage, and suggest a role for both WRN helicase
and exonuclease activities together with pol b during
LP BER.
INTRODUCTION
One of the major theories of aging proposes that the
phenotypical changes associated with age are due to the
accumulation of oxidatively induced DNA base lesions (1).
Base excision repair (BER) is the cellular repair pathway
responsible for the removal of these lesions and the restoration
of normal DNA bases. BER is divided into two sub-pathways,
in which one single nucleotide (SN) or greater than one (long
patch (LP)) nucleotide is incorporated during the repair pro-
cess. The major proteins involved in SN BER include DNA
glycosylases, apurinic/apyrimidinic endonuclease 1 (APE1),
DNA polymerase b (pol b) and DNA ligase. Notably, pol b
lacks 30–50 proofreading activity, making it susceptible to
incorporation errors (2), and mismatched bases have been
shown to impede further nucleotide incorporation (3,4) and
the ligation step (5). LP BER involves several additional pro-
teins, including ﬂap endonuclease 1 (FEN-1) and poly(ADP-
ribose) polymerase 1 (PARP-1), among others (6–8).
Werner syndrome (WS) is a segmental progeroid syndrome
in which patients appear much older than their chronological
age and display many clinical features resembling those of
normal aging. The protein defective in WS (WRN) is a mem-
ber of the RecQ family of DNA helicases, and possesses 30–50
exonuclease activity in addition to 30–50 helicase activity (9).
Neither the yeast or bacterial RecQ helicases possess
exonuclease activity, thus making the dual catalytic activities
of WRN quite unique. The N-terminal exonuclease domain
of WRN shows homology to the proofreading domain of
Escherichia coli DNA polymerase I (10) and WRN has a
proposed role as an autonomous proofreading enzyme (11).
Furthermore, WRN is able to degrade DNA substrates con-
taining a 30 G:T mismatch (12,13).
We have previously shown that WRN interacts with pol b
and stimulates pol b strand displacement DNA synthesis via
its helicase activity (14). In this report we investigated a role
for WRN exonuclease activity on 30 mismatches in coopera-
tion with pol b in vitro and a cellular role for WRN in BER
in vivo. We found that WRN exonuclease and helicase activ-
ities cooperated with pol b on BER intermediates containing
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doi:10.1093/nar/gkj47530 mismatched substrates. In addition, using cell lines stably
expressing small interfering RNAs (siRNA) against WRN,
we found that WRN knockdown (WRN KD) cells display
increased sensitivity to the methylating agent methyl methane-
sulfonate (MMS). Furthermore, extracts from WRN KD cells
displayed reduced LP BER. These results demonstrate
that WRN participates in BER in vivo and likely promotes
the efﬁciency of pol b-mediated BER via its helicase and
exonuclease activities.
MATERIALS AND METHODS
Materials
Synthetic oligodeoxyribonucleotides were purchased from
Midland Certiﬁed Reagent Co. (Table 1) or Oligos etc. Inc.
(see below). MMS and methoxyamine (MX) were from
Sigma. Hygromycin B was from Invitrogen and [a-
32P]dCTP
(3000 Ci/mmol) was from GE Healthcare. Recombinant
human WRN (15) and pol b (16) were puriﬁed as described.
Cell lines
The siRNAs targeted against WRN mRNA (UGAAGAG-
CAAGUUACUUGCUU) were cloned into the pSilencer 
3.1-H1 hygro vector (Ambion Inc.). The pSilencer  3.1-H1
negative control hygro vector (Ambion) was used to
express a scrambled siRNA with no signiﬁcant homology
to known human genes. Stable WRN KD and wild-type
(WT) cells were generated by transfection of U-2 OS
cells and selection by growing in 200 mg/ml hygromycin B
(W.-H. Cheng, R. Kusumoto, P.L. Opresko, X. Sui, S. Huang,
M.L. Nicolette, T.T. Paull, J. Campisi, M. Seidman,
V.A. Bohr, manuscript submitted). Individual clones were
selected and tested for levels of WRN KD by western blot
analysis and RT–PCR. The clone demonstrating the greatest
level of WRN KD was chosen for further analysis.
Telomerase-immortalized cell lines from a normal
(GM01604) and WS (AG03141) patient were described pre-
viously (17) and cultured in DMEM containing 10% fetal
bovine serum, glutamine, penicillin and streptomycin.
WRN exonuclease assays
Exonuclease reactions (10 ml) contained WRN and various
DNA substrates as indicated in exonuclease buffer [40 mM
Tris (pH 8), 4 mM MgCl2, 5 mM DTT, 0.1 mg/ml BSA and
4 mM ATP]. The concentrations of the DNA substrate and
WRN are indicated in the ﬁgure legend. In addition, molar
ratios were chosen based on optimal enzymatic activity
under the experimental conditions employed. Samples were
incubated for 15 min at 37 C and terminated by the addition of
formamide stop dye (80% formamide, 0.5· TBE, 0.1% bro-
mophenol blue and 0.1% xylene cyanol). Reaction products
were heat denatured for 5 min at 95 C and run on a 20%
denaturing polyacrylamide gel. Radioactive products were
visualized using a PhosphorImager and quantitated using
ImageQuant software.
Pol b extension assays
Reactions were performed in exonuclease buffer containing
100 mM dNTPs, pol b and WRN as indicated and were incu-
bated for 15 min at 37 C. The concentrations of the DNA
substrate, pol b and WRN are indicated in the ﬁgure legend
and were chosen based on enzymatic activity under the
reaction conditions employed. Reactions were terminated
and analyzed as above for exonuclease assays. For Figure 1C,
the fold increase was calculated as the % extension (total
extension products/total reaction products) for lanes con-
taining WRN and pol b divided by % extension for lanes
containing pol b alone.
WRN helicase assays
Helicase reactions (10 ml) were performed in exonuclease
buffer containing 1 mM dNTPs and DNA substrates
(250 fmol) as indicated. Reactions were initiated by the
addition of WRN (125 fmol), incubated for 15 min at 37 C
and terminated by the addition of stop dye (16 mM EDTA,
0.3% SDS, 13% glycerol, 0.05% xylene cyanol and 0.05%
bromophenol blue). Reaction products were run on a 12%
non-denaturing polyacrylamide gel and visualized using a
PhosphorImager.
Western blotting
Cells were pelleted, resuspended in SDS–protein sample
buffer and boiled for 5 min. Proteins were separated by
10% SDS–PAGE and transferred onto a PVDF membrane
(Bio-Rad). After blocking with 2.5% non-fat milk in
phosphate-buffered saline containing 0.1% Tween-20
(PBS-T) for 1 h at RT, the membrane was incubated overnight
at 4 C with the following primary antibodies: anti-actin
(Chemicon International, 1:2500), anti-WRN (BD Bio-
sciences, 1:250), anti-pol b (Trevigen, 1:250) or anti-lamin
A/C (Santa Cruz Biotechnology, 1:1000). After washing with
PBS-T, the membrane was incubated with the corresponding
horseradish peroxidase (HRP)-conjugated secondary anti-
bodies (Vector Laboratories, 1:10000) for 1 h at RT.
Antigen–antibody complexes were detected by enhanced
chemiluminescence using ECL Plus (Amersham Biosciences).
Cell survival assays
Cells were seeded at a density of 1 · 10
4 cells/well in 6-well
dishes. MMS (11.8 M) was initially diluted in PBS to make a
1 M stock, and subsequent dilutions were made directly into
the media. Cells were exposed to various concentrations of
MMS (0–1.25 mM) for 1 h at 37 C (5% CO2). Subsequently,
cells were washed twice with PBS and fresh media was
added. After incubation for 7 days, cells were counted by a
Table 1. Oligonucleotides used in this study
Name Sequence (50!30)
15P CTGCAGCTGATGCGC
15MMT CTGCAGCTGATGCGT
15MMG CTGCAGCTGATGCGG
15MMA CTGCAGCTGATGCGA
17P CTGCAGCTGATGCGCCG
17MMT CTGCAGCTGATGCGCCT
17MMC CTGCAGCTGATGCGCCC
17MMA CTGCAGCTGATGCGCCA
pG18 PGTACGGATCCCCGGGTAC
34G GTACCCGGGGATCCGTACGGCGCATCAGCTGCAG
p,phosphate.Mismatchedbasesintheprimerandtemplatestrandsareindicated
in bold.
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(Beckman Coulter, aperture 5 mm). Results were expressed as
the number of cells in drug-treated wells relative to cells in
control wells (% control growth).
Cytotoxicity studies were also conducted in the presence
of MX as described previously (19,20). A stock solution of
3 M MX was prepared in PBS immediately before use
and dissolved to a ﬁnal concentration (30 mM) in media to
which NaOH was added to adjust the pH to neutral.
Dilutions of MMS as indicated were prepared in the
MX-containing medium. Cells were incubated for 1 h at
37 C, washed twice with PBS and then incubated for an addi-
tional 3 h in media containing MX. Subsequently, cells were
washed twice with PBS, incubated in fresh medium for 7 days
at 37 C, and counted by the cell lysis procedure described
above.
Figure1.WRNexonucleaseactivitycooperateswithpolbon30 mismatches.(A)ADNAsubstrate(250fmol),containingcorrectlybasepaired(15P/34G,lanes1–3)
or mispaired (15MMT/34G, lanes 4–6; 15MMG/34G, lanes 7–9; 15MMA/34G, lanes 10–12) 30 termini opposite guanine, was incubated with WRN (0, 100 or
500fmol)for15minat37 C.ProductswererunondenaturingpolyacrylamidegelsandvisualizedusingaPhosphorImager.The30 recessedprimerisindicatedbyS.
(B) A DNA substrate (250 fmol), containing correctly base paired (17P/34G, lanes 1–3) or mispaired (17MMA/34G, lanes 4–6; 17MMT/34G, lanes 7–9;
17MMC/34G, lanes 10–12) 30 termini opposite cytosine, was incubated with WRN (0, 100 or 500 fmol) and analyzed as above. (C) Reactions containing
WRN (250 fmol, lanes 2 and 4) and pol b (10 fmol, lanes 3 and 4) were incubated with recessed substrate 15MMG/34G (250 fmol, left panel) or
17MMC/34G (250 fmol, middle panel) for 15 min at 37 C and analyzed as described above. Reactions containing WRN (300 fmol, lanes 2 and 4) and pol b
(3 fmol,lanes 3 and 4)were incubatedwith recessedsubstrate 17P/34G(250 fmol,right panel) for15 min at 37 C andanalyzed as described above. The 30 recessed
primer is indicated by the arrow. Extended products are indicated by the bracket.
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Cell extracts were prepared as described previously (21).
Brieﬂy, cells were washed twice with PBS at room
temperature, detached by scraping, pelleted by centrifugation
and resuspended in Buffer I [10 mM Tris–HCl (pH 7.8),
200 mM KCl and protease inhibitor cocktail (Boehringer
Mannheim)]. An equal volume of Buffer II [10 mM Tris–
HCl (pH 7.8), 200 mM KCl, 2 mM EDTA, 40% glycerol,
0.2% Nonidet P-40, 2 mM DTT and protease inhibitor
cocktail] was added. The suspension was rotated for 1 h at
4 C, and the resulting extract was clariﬁed by centrifugation
at 14000 r.p.m. (Soravall rotor SS-34) at 4 C for use in in vitro
BER assays. The protein concentration of the extract was
determined by Bio-Rad protein assay analysis using BSA as
a standard.
In vitro SN and LP BER assay
The BER assay was performed in a ﬁnal reaction volume
of 20 ml. A 35 bp duplex DNA oligonucleotide substrate
(250 nM) containing uracil (U) at position 15 (U strand: 50-
GCCCTGCAGGTCGAUTCTAGAGGATCCCCGGGTAC-30;
Template strand: 50-GTACCCGGGGATCCTCTAGAGT-
CGACCTGCAGGGC-30 ) was pre-incubated with WT or
WRN KD cell extract (20 mg) for 5 min at room temp in a
BER reaction mixture that contained 50 mM HEPES (pH 7.5),
0.5 mM EDTA, 2 mM DTT, 20 mM KCl, 4 mM ATP, 5 mM
phosphocreatine, 100 mg/ml phosphocreatine kinase, 0.5 mM
NAD and 100 mM ddTTP. The repair reaction was initiated
by the addition of 10 mM MgCl2 and 2.2 mM[ a-
32P]dCTP
(speciﬁc activity, 1 · 10
6 dpm/pmol) and incubated at 37 C.
Aliquots (5 ml) were removed at the indicated periods. The
reaction was terminated by the addition of an equal volume
(5 ml) of DNA gel loading buffer (95% formamide, 20 mM
EDTA, 0.02% bromophenol blue and 0.02% xylene cyanol).
After incubation at 75 C for 2 min, the reaction products were
separated by electrophoresis in a 15% polyacrylamide gel
containing 8 M urea in 89 mM Tris–HCl (pH 8.8), 89 mM
boric acid and 2 mM EDTA. The gels were scanned by
PhosphorImager and the data was analyzed by ImageQuant
software.
RESULTS
We have previously shown that the WRN helicase stimulates
pol b strand displacement DNA synthesis (14), thereby
indicating a mechanism by which WRN promotes BER. To
further investigate the biochemical mechanism for WRN’s
role in promoting BER, we next tested for the possible con-
tribution of the WRN exonuclease in pol b-directed BER.
Given that pol b lacks proofreading activity, we hypothesized
that the WRN exonuclease may cooperate with pol b to correct
misincorporated bases. Therefore, using a variety of 30 mis-
matchedsubstrates including purine:purine, purine:pyrimidine
and pyrimidine:pyrimidine pairs, we ﬁrst tested the ability of
WRN to excise 30 mismatches in the context of a primer/
template. The helicase is inactive on this substrate, allowing
us to examine the contribution of the WRN exonuclease on
pol b DNA synthesis. WRN excised cytosine (Figure 1A,
lanes 2 and 3), guanine (Figure 1A, lanes 8 and 9) and adenine
(Figure 1A, lanes 11 and 12) when paired opposite guanine,
but poorly excised thymine (Figure 1A, lanes 5 and 6). The
speciﬁc activity of the WRN exonuclease on these 30 recessed
substrates opposite G was C > A   G > T (Table 2). On 30
recessed substrates containing correctly or mispaired bases
opposite cytosine, the WRN exonuclease was active on all
four substrates (Figure 1B). In this case,the WRN exonuclease
preferred an A:C mispair, with A > G   T   C (Table 2).
Given the ability of WRN to efﬁciently excise 30 mismatches,
we examined for cooperativity with pol b, since a mismatched
primer terminus is a poor substrate for pol b primer extension
(3,4). WRN excised a G:G mispair, resulting in a predo-
minately 14 nt product (Figure 1C, left panel, lane 2). We
observed limited extension by pol b alone (Figure 1C, left
panel, lane 3), however, the presence of WRN resulted in a
15-fold increase in the percent of products extended by pol b
(Figure 1C, left panel, lane 4). Similarly, on a recessed
substrate containing a 30 C:C mispair, WRN was able to excise
the mismatch (Figure 1C, middle panel, lane 2) allowing for
incorporation by pol b (Figure 1C, middle panel, lane 4).
WRN increased the percent of extended products 10-fold
(Figure 1C, middle panel, lane 4) compared to pol b alone
(Figure 1C, middle panel, lane 3). As expected, on a recessed
substrate with correctly paired 30 termini, pol b extension
was similar in the absence or presence of WRN (Figure 1C,
right panel, lanes 3 and 4). These results suggest that the
WRN exonuclease has the capability to excise mismatches
following misincorporation of nucleotides by pol b.
Based on our ﬁndings that the WRN exonuclease removed
several 30 mismatches in the context of a recessed DNA sub-
strate, we next wanted to determine whether the WRN helicase
could unwind gap substrates containing a 30 mismatch. As
shown in Figure 2A, WRN was able to displace the down-
stream oligonucleotide from substrates with either correctly
paired nucleotides (lane 2) or G:G (lane 4) and A:G (lane 6)
mismatches. The gapped substrates unwound by WRN
migrated to the same position as a recessed substrate,
which was used as a marker (Figure 2A, lane 7). Following
our observations that WRN unwound from a gap containing
a3 0 mismatch, we next evaluated both exonuclease and
helicase activities of WRN on the same substrates, with and
without pol b. We found that similar to the recessed substrates,
WRN was able to degrade from gapped substrates containing
correctly paired 30 termini (Figure 2B, lanes 2 and 4) or A:G
mispairs (Figure 2B, lanes 6 and 8). In addition, pol b
incorporated predominantly 1 nt (Figure 2B, lanes 3 and 7).
However, the presence of WRN resulted in a stimulation of
Table 2. WRN excision of paired and mispaired substrates
Primer:Template Exonuclease activityofWRN (fmolDNA/min)
100 fmol WRN 500 fmol WRN
C:G 1.06 ± 0.32 3.86 ± 0.81
T:G 0.13 ± 0.03 0.42 ± 0.05
G:G 0.53 ± 0.17 1.92 ± 0.47
A:G 0.65 ± 0.19 2.01 ± 0.15
G:C 0.46 ± 0.49 1.77 ± 1.04
A:C 1.11 ± 1.02 3.29 ± 1.46
T:C 0.55 ± 0.33 1.63 ± 0.83
C:C 0.50 ± 0.39 1.84 ± 0.88
Values represent the mean ± SD of three independent experiments.
748 Nucleic Acids Research, 2006, Vol. 34, No. 2pol b strand displacement synthesis and longer products
(Figure 2B, lanes 4 and 8). These results demonstrate that
both WRN helicase and exonuclease activities can potenti-
ally function together on BER strand break intermediates
containing correct or mispaired 30 termini.
Based on our in vitro data that WRN helicase and exonu-
clease activities cooperate with pol b on BER intermediates,
we next focused on whether WRN participates with pol b
in vivo during BER. We therefore generated stable cell
lines containing either an siRNA targeting WRN mRNA
(WRN KD) or an siRNA negative control (WT) with a
sequence that has no signiﬁcant similarity to human genes
(see Materials and Methods). We determined by real-time
RT–PCR that WRN mRNA levels were decreased 3-fold in
WRN KD cells compared to WT cells (data not shown). In
addition, the WRN KD cells contained undetectable levels of
WRN protein comparedto WTcells,while levels ofactinwere
similar between the two cell lines (Figure 3A). The reduction
in WRN levels in the stable cell lines was maintained
even after 20 passages (data not shown). Furthermore,
while WRN protein levels were signiﬁcantly reduced in
the KD cells, pol b levels were not affected (Figure 3B).
To conﬁrm that the WRN KD cells behaved similar to WS
cells, we measured cellular survival by colony formation
following treatment with mitomycin C (MMC) or camp-
tothecin (CPT). WRN KD cells were more sensitive to both
MMC and CPT (data not shown). Similar results were also
observed following treatment of WT and WRN KD cells with
MMC or CPT and measurement of cellular proliferation using
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT, data not shown). These results are consistent
with previously published reports demonstrating that cells
lacking the WRN protein display increased sensitivity to
CPT and DNA cross-linking agents (22–25) In summary,
these results demonstrate that the WRN KD cells have
signiﬁcantly reduced levels of WRN protein, and that knock-
down of WRN confers sensitivity to DNA damaging agents
similar to that of WS cells.
As pol b-mediated BER is important for the repair of
alkylation-induced DNA base damage, we investigated the
inﬂuence of WRN on cellular survival in the presence of
the methylating agent MMS. MMS is a SN2 methylating
agent and can generate 7-methylguanine, 3-methyladenine,
1-methyladenine and 3-methylcytosine lesions (26). Follow-
ing incubation of cells with MMS, and measurement of
cellular survival, we found that WRN KD cells were more
sensitive to MMS compared to WT cells (Figure 4A). The
lethal dose at 37% (LD37) for WRN KD cells was
0.68 mM MMS and 1.15 mM MMS for WT cells. Therefore,
the down-regulation of WRN resulted in a 1.7-fold increased
sensitivity to MMS. We also investigated the sensitivity
of WS ﬁbroblasts to MMS. Similar to the results observed
with WRN KD cells, we found that WS cells were hyper-
sensitive to MMS compared to normal cells (Figure 4B).
The LD37 for WS and WT cells was 0.15 and 0.75 mM
MMS, respectively. Thus, WS cells displayed a 5-fold higher
sensitivity to MMS compared to WT cells. As MMS-mediated
DNA damage is repaired, at least in part, by SN BER, these
results suggest that WRN plays a role in SN BER. To inves-
tigate a role for WRN in LP BER of MMS-induced DNA
lesions, we performed survival assays in the presence of
MX. MX can react with the aldehydic C10 atom of an abasic
site rendering it refractory to b-elimination by pol b dRP lyase
activity (19), thus blocking SN BER. Incubation of WRN KD
cells with MMS in the presence of MX resulted in decreased
cellular survival compared to WT cells (Figure 4C). WRN
KD cells were 1.6-fold more sensitive to MMS in the presence
of MX compared to WT cells, as determined by the LD37
(0.35 and 0.58 mM MMS for WRN KD and WT cells, res-
pectively). Thus together, these results suggest that WRN is
also important for the repair of MMS-induced DNA damage
via both the SN and LP pathway of BER.
Figure 2. WRN exonuclease and helicase act on gapped substrates with 30
internal mismatches together with pol b.( A) A DNA substrate (250 fmol),
containing correctly base paired (15P/pG18/34G, lanes 1 and 2) or mispaired
(15MMG/pG18/34G, lanes 3 and 4; 15MMA/pG18/34G, lanes 5 and 6)
nucleotides opposite guanine in the context of a 1 nt gap, was incubated with
WRN (125 fmol) for 15 min at 37 C. Reaction products were run on a native
polyacrylamide gel and visualized using a PhosphorImager. Lane 7, 15P/34G
(250fmol).Lane8,heatdenatured15P/34G(250fmol).(B)Reactionscontain-
ing WRN (250 fmol, lanes 2, 4, 6 and 8) or pol b (10 fmol, lanes 3, 4, 7 and 8)
were incubated for 15 min at 37 C with gapped DNA substrates (250 fmol)
containing correctly paired (15P/pG18/34G, lanes 1–4) or mispaired
(15MMA/pG18/34G, lanes 5–8) nucleotides. Products were separated on a
denaturing polyacrylamide gel and visualized using a PhosphorImager. The
positionofthe15ntlabeledoligonucleotideisindicated.Extendedproductsare
indicated by the bracket.
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we developed a modiﬁed BER assay in which the ﬁrst
nucleotide incorporated was [
32P]dCMP and the second
incorporated by LP BER was a chain terminating ddNMP
instead of a normal dNMP. This assay speciﬁcally examines
pol b-mediated LP BER activity as ddNTPs can be utilized
by pol b, but not by the replicative polymerases. In addition,
since the substrate is a 35 bp oligonucleotide duplex,
contributions by PCNA-dependent polymerases are excluded.
Thus, the labeled in vitro BER products are the fully repaired
and ligated 35mer SN BER product, the 16mer product
representing a LP BER intermediate (2 nt incorporated),
and the 15mer product (1 nt incorporated) representing either
SN or LP BER intermediates (Figure 5A). Since the fate of
the 15mer product could eventually be either SN or LP BER,
quantiﬁcation of this product was not included (see below).
In the experiment shown in Figure 5B, the BER reaction
was conducted with extracts from WT and WRN KD cells
and the reaction products were analyzed after a 10 min incuba-
tion. The results indicated that the amount of the SN BER
product in the WRN KD extract was slightly reduced
(1.2-fold) compared with WT extract, and the LP BER (2 nt
incorporated)productwas reduced2-fold(Figure5B, compare
lanes 1 and 2). A time-course of in vitro BER with WT and
WRN KD extracts revealed that WRN KD extracts had
reduced levels ( 2-fold) of the LP BER intermediate
(16mer) at each time point examined (Figure 5C and D).
The quantitation of LP BER products is shown in
Figure 5D and demonstrates a deﬁciency in LP BER in the
WRN KD extracts compared with the WT extracts. While the
experiment shown in Figure 5D represents one of four similar
assays, the average fold-decrease in the LP BER product
(16mer), as a function of WRN down-regulation, is shown
in Figure 5E. Thus, our results demonstrate a role for WRN
in cell extract-mediated LP BER.
DISCUSSION
In this study, we characterized WRN exonuclease activity
on 30 mismatches in cooperation with pol b and examined
a cellular role for WRN in BER. We found that the WRN
exonuclease removed 30 mismatches in the context of
recessed and gapped substrates. In addition, WRN and
pol b acted cooperatively on BER intermediates containing
30 mismatches. We also demonstrated that a down-regulation
of WRN expression resulted in elevated cellular sensitivity to
MMS and greatly reduced LP BER in vitro using whole cell
extract assays. These ﬁndings provide further support that
WRN participates in pol b-directed repair of DNA damage.
We have previously demonstrated a physical and functional
interaction between WRN and pol b (14). Furthermore, we
have recently shown that WRN unwinds several single-strand
break BER intermediates, and that this unwinding activity is
regulated by the presence of APE1 and pol b (27). As WRN
also possesses 30–50 exonuclease activity, and pol b lacks
proofreading activity, we examined in this report for coopera-
tivity between WRN and pol b on 30 mismatch-containing
substrates. The WRN exonuclease degraded most of the 30
mispairs examined, and in doing so, was able to promote
incorporation by pol b. Furthermore, both WRN exonuclease
and helicase activities operated together, and in cooperation
with pol b, to facilitate processing of strand break inter-
mediates. As shown in Figure 2B, the primer strand was
degraded by WRN, albeit to a lesser extent, even in the pres-
ence of ongoing DNA synthesis by pol b. This may indeed
be reﬂective of an initial 30 end processing by exonucleases,
such as WRN, on certain DNA lesions in vivo, or alternatively,
degradation of the 30 termini may be limited by the cellular
localization of WRN and/or the concentration of WRN
relative to pol b at the site of the DNA damage. In a similar
fashion, the 50 termini may determine whether pol b inserts
predominantly 1 nt, or strand displacement synthesis is
required to facilitate repair. For example, if the 50 dRP is
oxidized and refractory to pol b dRP lyase activity, WRN
helicase activity could stimulate pol b stand displacement
synthesis in vivo and promote LP BER. In conclusion,
while the WRN exonuclease did not preferentially excise
30 mismatches, these ﬁndings coupled with our previous
results suggest a model whereby the two catalytic activities
of WRN may be important and may cooperate during pol
b-directed BER.
As shown here for WRN, APE1 (28) and TREX1 (29,30)
have also been found to excise nucleotides misincorporated
Figure3.CharacterizationofWRNKDcells.(A)LevelsofWRN.PelletsfromWTandWRNKDcellswerelysedinsamplebufferandincreasingvolumes(1,2,5or
10ml)asindicatedwereloadedon10%SDS–PAGEgels.Westernblotswereperformedusinganti-WRNandanti-actinprimaryantibodiesasindicated.(B)Levelsof
pol b. Equal concentrations of WT and WRN KD extracts were loaded on SDS–PAGE gels. Western blots were performed using anti-pol b and anti-lamin A/C
primary antibodies as indicated.
750 Nucleic Acids Research, 2006, Vol. 34, No. 2by pol b. Thus, these proteins may provide redundant or com-
pensatory editing activities for this error-prone polymerase.
Which exonuclease is called upon in vivo may be dictated
by the intracellular environment, protein–protein interactions,
DNA sequence, or the nucleotide mismatch. For example,
we note that the mismatch least excised by WRN, T:G, is a
preferred mismatch of APE1 (28,31). Cooperativity between
WRN and pol b may also be important in certain sequence
contexts, such as trinucleotide repeat sequences and guanine-
rich regions, which form secondary structures such as
hairpins and G4 quadruplexes. Expansion of triplet repeats
by pol b has been shown to be due to its limited strand
displacement activity (32), and WRN is efﬁcient at catalyzing
the unwinding of many alternate DNA structures including
Holliday junctions, triple helices and G4 quadruplexes
(33,34). In the event that pol b misincorporates a nucleotide,
the WRN exonuclease could excise the mismatch. Thus,
WRN may serve to facilitate strand displacement and
enhance the ﬁdelity of DNA repair via its combined helicase
and exonuclease activities, particularly during LP repair
synthesis.
As the understanding of LP BER is continually emerging, as
is the number of proteins involved in this repair pathway,
which speciﬁc protein or protein complex is called upon
in vivo will likely be determined by the DNA damaging
agent and the speciﬁc lesion generated. PARP-1 has been
identiﬁed as a component of a BER protein complex (7)
and has been shown to stimulate LP BER in the presence
of FEN-1 (8). In addition, it has recently been shown that
FEN-1 stimulates LP BER in vitro by creating short 1 nt
gap products which are favorable substrates for pol b
gap-ﬁlling activity (35). WRN physically and functionally
interacts with many of the proteins involved in LP BER,
including pol b, PARP-1 and FEN-1 (36), and in this report
we demonstrate for the ﬁrst time that extracts down-regulated
for WRN protein expression are deﬁcient in LP BER. This
also represents the ﬁrst reported association between a
human disorder and a speciﬁc deﬁciency in LP BER.
We also demonstrate that both WS and WRN KD cells were
hypersensitive to MMS. Consistent with our ﬁndings in
human cells, Imamura et al. (37) observed that WRN
 / 
chicken DT40 cells displayed elevated sensitivity to MMS.
Furthermore, it was recently shown using antisense oligo-
nucleotides that WRN KD cells were hypersensitive to the
methylating agents methyl-lexitropsin and temozolomide
compared to isogenic controls (38). Together these results
suggest that WRN participates in the repair of methylation-
induced DNA damage and thus confers cellular survival. This
is most likely through a role of WRN in pol b-mediated BER.
In support of this conclusion, we found that extracts from
WRN KD cells have reduced SN and LP BER activities
in vitro, which are consistent with the in vivo cellular sensi-
tivity assays. The observation that WRN KD cells were more
sensitive to MMS in the presence of MX suggests that WRN
participates in LP BER. Consistently, we observed a signiﬁ-
cant decrease in LP BER using WRN KD extracts in vitro.
The sensitivity of WRN KD cells to MMS alone, compared to
isogenic controls, indicates a role for WRN in SN BER. In
addition, extracts from WRN KD cells had slightly lower SN
BER of a uracil-containing substrate. The observation that
the survival studies with MMS alone were more dramatic
than the in vitro BER results may reﬂect an additional role
for WRN in the processing of stalled replication forks and/or
DNA double-strand break (DSB) repair. MMS-induced DNA
damage can result in the stalling of replication forks (39,40)
and the formation of DSBs, as evidenced by the phosphory-
lation of histone H2AX (41,42). In addition, when cells lack-
ing pol b are treated with MMS, unrepaired single-strand
breaks are converted to DSBs during S phase, and become
substrates for homologous recombination (43). Thus, if WRN
participates in the BER of MMS-induced DNA damage,
Figure 4. WRN KD cells show elevated sensitivity to methylation damage.
(A) WT and WRN KD cells were incubated in the absence or presence of
MMS(0–1.25mM)for1hat37 C.Survivalcurvesweregeneratedasdescribed
in Materials and Methods. Values represent the mean ± SD of four experi-
ments. (B) WT (GM01604) and WS (AG03141) cells were incubated in the
absenceorpresenceofMMS(0–1.25mM)for1hat37 C.Survivalcurveswere
generated as described in Materials and Methods. Values represent the
mean ± SD of three or four experiments. (C) WT and WRN KD cells were
incubatedwithMMSasindicatedinthepresenceof30mMMXfor1hat37 C.
Cellswerethenincubatedforanadditional3hat37 CwithMX(30mM)alone.
Survival curves were generated as described in Materials and Methods. Values
represent the mean +/  SEM of three experiments.
Nucleic Acids Research, 2006, Vol. 34, No. 2 751as suggested by this study, the absence of WRN may lead to
increased replication fork arrest and/or DSBs during
replication. As WRN has also been shown to participate in
DSB repair (25,44), the decreased cellular survival of WRN
KD cells observed here may also be due in part to WRN’s
role in DSB repair.
Recently Szekely etal. (45) reportedthat the KD of WRN in
primary human ﬁbroblasts results in increased DNA damage
following oxidative stress, particularly in non-dividing cells.
As BER is important for the repair of both oxidation and
alkylation-mediated DNA damage, our results presented
here are consistent with their ﬁndings, and with a speciﬁc
role for WRN in BER.
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